AssessinG Efficacy of Carboplatin and ATezOlizumab in Metastatic Lobular Breast Cancer

Stopped At interim analysis insufficient benefit was observed to continu the study

Conditions

• Breast Cancer

Interventions

• DRUG: Carboplatin
• DRUG: Atezolizumab

Sponsor

The Netherlands Cancer Institute

Collaborators

• [object Object]